A
Actelion Pharmaceuticals
Actelion Pharmaceuticals Ltd: We focus on the discovery, development, and commercialization of innovative treatments for diseases with high unmet medical needs.
At a glance
- Founded
- 1997
- Headquarters
- Allschwil, Switzerland
- Listing
- IPO 2013
- Sector
- Biotech & Life Sciences
- Power Law
- Decacorn$10B+ valuation tierThoroughbred$100M+ revenue
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
- RCReference Capital
- HEHealthCap
Atlas Venture
Sofinnova Partners
Source: Dealroom Talent Intelligence.
Alumni founders
Former Actelion Pharmaceuticals employees who went on to found companies, sorted by Dealroom signal score.
Isaac KobrinSwitzerland
Alexandre MottaBrazil
IOIonpathEst. 2014
Harris FienbergUnited States
IDIdorsiaEst. 2017
Jean-Paul ClozelSwitzerlandGlobal footprint
team presence
across markets
Patents
127 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Investments and acquisitions
Disclosed deals where Actelion Pharmaceuticals was the backer or acquirer, 2003–2017. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
4 deals across Actelion Pharmaceuticals's capital deployment.
Where the deals concentrate by sector, stage, and decade.
Actelion Pharmaceuticals's portfolio, mapped.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Actelion Pharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Actelion Pharmaceuticals on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.